SCHEMBL27865868

SCHEMBL27865868

CS(=O)(=O)NCC(C(N)=O)c1ccccc1C(F)(F)F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CNR2 P34972 2/20 0.42
▸ MMP7 P09237 1/20 0.40
▸ MC4R P32245 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ ACP3 P15309 1/20 0.37
▸ MAPK1 P28482 2/20 0.36
▸ POLB P06746 1/20 0.36
▸ PER2 O15055 1/20 0.36
▸ CRY1 Q16526 1/20 0.36
▸ CRY2 Q49AN0 1/20 0.36
▸ SLC9A1 P19634 1/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ CYP1A2 P05177 2/20 0.35
▸ CYP3A4 P08684 2/20 0.35
▸ CYP2C9 P11712 2/20 0.35
▸ TSHR P16473 2/20 0.35
▸ CYP2C19 P33261 2/20 0.35
▸ MAPT P10636 1/20 0.35
▸ HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27848977 0.90 CNR2 (0.40) CNR2MMP7LMNAGAAACP3
SCHEMBL27848983 0.83 CNR2 (0.41) CNR2MMP7ACP3MAPK1POLB
SCHEMBL10216817 0.83 MC4R (0.41) CNR2MMP7MC4RGAAACP3
Hydrochloric Acid SCHEMBL3446624 0.82 MC4R (0.40) CNR2MMP7MC4RGAAACP3
SCHEMBL2699407 0.80 CNR2 (0.44) CNR2MC4RACP3MAPK1POLB
SCHEMBL3448694 0.79 CNR2 (0.46) CNR2MMP7MC4RACP3MAPK1
SCHEMBL28796970 0.78 CNR2 (0.46) CNR2LMNAGAAACP3MAPK1
SCHEMBL27848985 0.75 EPHX1 (0.46) MMP7POLBSMN1; SMN2CYP1A2CYP3A4
SCHEMBL382042 0.75 CNR2 (0.40) CNR2MMP7MC4RACP3POLB
SCHEMBL6017225 0.75 CYP1A2 (0.43) CNR2ACP3MAPK1POLBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102438990-A Substituted 2-acetamido-5-aryl-1, 2, 4-triazolones and use thereof BAYER SCHERING PHARMA AG 2012-05-02 — — CN disclosed
Send feedback